Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M532Revenue $M47.1Net Margin (%)0Z-Score5.2
Enterprise Value $M390EPS $-2.6Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $-1.3Pre-tax Margin (%)0Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %0Quick Ratio6.0Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %17.2Current Ratio6.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-55.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-63.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.5ROI % (ttm)-69.4Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIJohn Burbank 2014-06-30 Sold Out -0.01%$8.6 - $12.67
($10.38)
$ 10.945%Sold Out0
INFIJohn Burbank 2014-03-31 Buy 0.01%$11.37 - $16.52
($13.45)
$ 10.94-19%New holding, 16556 sh.16,556
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 10.94-65%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 10.94-72%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 10.94-57%New holding, 75000 sh.75,000
INFIJean-Marie Eveillard 2012-06-30 Sold Out -0.01%$11.71 - $13.76
($12.78)
$ 10.94-14%Sold Out0
INFIJean-Marie Eveillard 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 10.9437%Reduce -54.94%180,000
INFIJean-Marie Eveillard 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 10.9439%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 10.9468%Sold Out0
INFIJean-Marie Eveillard 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 10.9478%Add 60.34%585,437
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 10.9478%Reduce -63.91%7,415
INFIJean-Marie Eveillard 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 10.9498%Add 29.72%365,123
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 10.9498%Reduce -25.39%20,545
INFIJean-Marie Eveillard 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 10.9466%Add 566.95%281,460
INFIJean-Marie Eveillard 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 10.9485%Add 451.43%42,201
INFIJean-Marie Eveillard 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 10.9457%New holding, 7653 sh.7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 10.9438%New holding, 28437 sh.28,437
INFIJean-Marie Eveillard 2008-12-31 Buy $4.73 - $8.05
($6.3)
$ 10.9474%New holding, 28100 sh.28,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
INFI John Burbank 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Palombella Vito J.Chief Scientific Officer 2014-07-01Sell879$12.87-15view
Palombella Vito J.Chief Scientific Officer 2014-02-25Sell4,736$15-27.07view
Palombella Vito J.Chief Scientific Officer 2014-01-02Sell753$13.52-19.08view
EVNIN ANTHONY BDirector 2013-12-02Sell17,756$14.56-24.86view
EVNIN ANTHONY BDirector 2013-11-27Sell163,864$14.82-26.18view
Palombella Vito J.Chief Scientific Officer 2013-09-27Sell4,736$17.28-36.69view
Perkins Adelene QPres & CEO 2013-09-13Sell45,000$20.72-47.2view
Palombella Vito J.Chief Scientific Officer 2013-06-20Sell23,150$18.53-40.96view
Rosebay Medical Co L.P.10% Owner 2013-04-16Sell5,708,283$38.4-71.51view
Beacon Co10% Owner 2013-04-16Sell5,708,282$38.4-71.51view

Press Releases about INFI :

    Quarterly/Annual Reports about INFI:

    News about INFI:

    Articles On GuruFocus.com
    comment on INFI Mar 02 2013 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
    Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

    More From Other Websites
    INFINITY PHARMACEUTICALS, INC. Financials Aug 19 2014
    INFINITY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
    Traders see no going back for Infinity Aug 06 2014
    Infinity Reports Second Quarter 2014 Financial Results and Provides Company Update Aug 05 2014
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 05 2014
    Infinity Reports Second Quarter 2014 Financial Results and Provides Company Update Aug 05 2014
    Q2 2014 Infinity Pharmaceuticals, Inc. Earnings Release - Before Market Open Aug 05 2014
    Infinity Amends PI3K-Delta, Gamma Agreement with Millennium Aug 04 2014
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Aug 04 2014
    Infinity Amends PI3K-Delta, Gamma Agreement with Millennium Aug 04 2014
    Infinity Announces the Date of Its Second Quarter 2014 Financial Results Conference Call and Webcast Jul 24 2014
    Infinity Announces the Date of Its Second Quarter 2014 Financial Results Conference Call and Webcast Jul 24 2014
    Infinity to Participate in the BMO Capital Markets 3RD Annual Biotech Corporate Access Day Jul 22 2014
    Infinity to Participate in the BMO Capital Markets 3RD Annual Biotech Corporate Access Day Jul 22 2014
    3 Small-Cap Biotechs That Institutions Are Loving Jul 07 2014
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jun 19 2014
    Five Biotech Stocks With Big Potential And Billionaire Believers Jun 16 2014
    Infinity to Present at the Goldman Sachs 35th Annual Global Healthcare Conference Jun 03 2014
    Infinity to Participate in Four Conferences in June May 27 2014
    Gilead study 'alarming,' says Stifel May 15 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide